Association of Community Cancer Centers

Cancer education and advocacy organization

Based in MD

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 34 quarterly filings, Association of Community Cancer Centers is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$40K
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$20K
2019$0
2020$0
2021$20K
2022$0
2023$0
2024$0
2025$0

Issues Lobbied

Health IssuesMedicare/MedicaidGovernment Issues

Lobbying Firms

(C) Management INC.

Lobbyists

Leah RalphBlair BurnettKristin Ferguson

Government Agencies Targeted

These are the government entities that Association of Community Cancer Centers disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Government Issues

Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409))

Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Educa

Excluding Part B payments from CMS' Merit Based Incentive Payment System (MIPS) adjustment under the Quality Payment Program (QPP)

Reimbursement for care planning for cancer patients in the Medicare P

Preserving patient protections in a repeal of the Affordable Care Act (ACA)

Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)

Flexibility in implementing CMS' Quality Payment Program

Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)

ACCC advocated to the US House of Representatives and US Senate on the following issues: (1) passage of a federal oral parity bill in US Congress in support of H.R. 1730 (Cancer Drug Parity Act of 201

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Alterwood Health
$110K total spend
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Digestive Health Physicians Association, INC.
$2.0M total spend
American Society of Addiction Medicine
$1.9M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.